MSCI global small-cap index adjustment imminent, DUALITYBIO-B(09606) and others will be included.
On August 8, MSCI, a globally renowned index company, announced the results of the index quarterly review for August 2025. In this adjustment, many companies including Innovent Biologics-B (09606) will be included in the MSCI Global Small Cap Index, officially entering the "global assets" category.
On August 8th, the globally renowned index company MSCI announced the results of the index quarterly review for August 2025. In this adjustment, several companies including DUALITYBIO-B (09606) will be included in the MSCI Global Small Cap Index, officially joining the ranks of "global assets".
This adjustment will take effect after the close of trading on August 26th. The closing auction transaction of the newly added companies will be enlarged on the same day, as passive funds concentrate on buying, with limited short-term stock price impact. However, in the long run, they will continue to benefit from funds, valuation, and brand aspects.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


